European Heart Journal Acceptance Rate

The ESC journal page describes EHJ as its general cardiology journal, covering clinical and scientific aspects of cardiovascular medicine. Oxford Academic provides the journal's articles and publication context. The about page describes original research, reviews and other material across cardiovascular medicine, including ESC guidelines.

Those statements do not establish that every submitted paper must change a guideline, use a multicenter design, or enroll a minimum number of patients. The previous fixed sample-size and automatic rejection claims in this guide were unsupported and have been removed.

The checked pages publish citation and journal information without a current acceptance-rate denominator. This finding is bounded to the pages checked. A historical editorial, annual report or later update might provide additional data, but it should be labeled with its own period and population before use.

A desk rejection and a rejection after external review occur at different stages. A statistic covering only externally reviewed manuscripts excludes the submissions returned earlier. Article types can also have different submission and decision processes, so check whether a reported total combines research articles, reviews or invited material.

This guide has not established an EHJ-specific split between those stages or article types. Keep that missing denominator visible when a third-party page presents a precise rate. The hypothetical example below explains the arithmetic without supplying invented journal data.

A journal-wide rate combines manuscripts with different article types, methods, topics and levels of completeness. It cannot tell you which part of your paper needs work. Nor can it tell you that a paper from a particular institution or study setting is likely to be accepted.

Hypothetical example: two different denominators. Imagine a journal receives 1,000 submissions, sends 200 for external review and eventually accepts 80. Its all-submission rate would be 8%, while its reviewed-manuscript rate would be 40%. These are two descriptions of the same imaginary flow. Neither is an EHJ statistic.

The mistake would be to compare the 40% figure with another journal's all-submission figure and conclude that the first journal is easier. Even a correctly divided fraction becomes misleading when the underlying populations differ.

If a published number does not explain which denominator it uses, keep it out of a numerical venue ranking. Ask for the source definition or use the available scope and preparation evidence instead.

An impact factor is a citation measure. It does not provide the submitted-manuscript count needed to calculate an acceptance rate. Publication volume does not supply that missing denominator either: counting published articles alone tells you nothing definite about how many manuscripts were rejected.

For dated citation information, consult Journal Citation Reports and the official journal's metric labels. The prior conflicting values in this acceptance-rate guide are removed rather than used to imply selectivity. SCImago's journal record is another distinct citation-ranking resource, not a substitute acceptance dataset.

A higher citation average also does not prove that one individual study is more valuable than another. Keep the paper's question, evidence and limitations visible when discussing venue choice with coauthors.

The useful review task is to find the gap between the claim and the evidence. A large sample cannot rescue an inappropriate comparison, and a single-center design is not by itself proof that a study is uninformative.

These are Manusights editorial checks, not a list of secret EHJ screening rules. They help produce a reviewable draft regardless of whether the editor ultimately considers it a fit.

Consider a hypothetical single-center observational study reporting an association between a biomarker and an outcome. The question is not whether it crosses an arbitrary patient-count threshold. Ask what the study can estimate, how participants entered the dataset, which sources of bias remain, and whether the conclusion describes association or claims an intervention benefit.

If the authors cannot distinguish those statements, a larger title claim will not solve the problem. They should correct the framing and discuss the limitations. If the paper's contribution remains valuable within its studied population, that contribution can be assessed honestly against candidate journals.

Now consider a multicenter study. Multiple centers may broaden the setting, but differences in measurement or recruitment can introduce their own interpretation problems. The authors still need to explain those differences. “Multicenter” is not a substitute for a coherent analysis.

Neither example predicts an EHJ decision or instructs authors to expand their scientific scope. Both illustrate why a journal-wide acceptance number is an incomplete planning tool.

Compare EHJ with another venue by keeping the manuscript constant. Write the same contribution sentence above two columns, then explain the audience match for each journal. Do not silently broaden the claim for the venue you prefer.

A journal can be an appropriate alternative without being described as easier, less rigorous or a guaranteed acceptance route. If the comparison requires changing the research question, stop and reassess whether it is still the same paper.

For your planning, read the European Heart Journal cover letter guide and European Heart Journal review time guide. Keep timing and budget as separate constraints rather than proxies for acceptance.

Create one short decision note for the coauthors. Include the exact journal, intended article type, contribution sentence, unresolved manuscript issues, official sources checked and who is responsible for each next action.

If an acceptance number is included, record its original source, data year and denominator. If those fields are unavailable, write that explicitly. Do not allow an estimate to become more authoritative each time it is copied into another planning document.

Set a date to revisit unresolved questions. That date is your team's planning choice, not a claimed EHJ response deadline. Separate time reserved for author revisions from time that depends on editorial handling.

A useful note ends with a decision that can be acted on: submit the approved version, repair named issues, or compare a specified alternative. It does not end with an unsupported percentage.